MIRIQA® Dermabiotics

MIRIQA® Dermabiotics is a synergistic blend of 10 billion postbiotics and 30 billion probiotics, along with prebiotics and Vitamin D3. This formula is designed to support the gut-skin axis, nourish the gut, calm inflammation, and promote healthier skin from within. It utilizes a quadruple patented encapsulation technology (QSHIELD®) to ensure the strains reach the gut effectively. This product is suitable for infants (3+ months), children, adults, and pregnant/breastfeeding women with a family history of atopic dermatitis (AD).

10 Billion Postbiotics: Bioactive by-products of probiotics, specifically RHT3201. RHT3201 is the first postbiotic approved by KFDA, effective and safe in immune regulation, and clinically proven to reduce hypersensitivity and alleviate AD symptoms.

30 Billion Probiotics: Live beneficial bacteria including:

• Lactobacillus Rhamnosus GG: Clinically researched for skin health, showing evidence of reducing eczema risk.
• Lactobacillus Salivarius IDCC 3551: Clinically demonstrated to modulate the gut-skin axis, suppress Th2-driven inflammation, and strengthen skin barrier function.
• Lactobacillus Casei IDCC 3451: Helps modulate immune responses and reduce skin inflammation.
• Lactobacillus Plantarum IDCC 3501: Strengthens the skin barrier and reduces inflammation.
• Bifidobacterium Lactis IDCC 4301: Helps calm immune overactivity and restore skin balance.

Prebiotics: Fructooligosaccharides and Chicory Dietary Fibre, which serve as food for probiotics. They have been shown to reduce itching and sleep disturbance, and enhance skin barrier lipids.

Vitamin D3: Often found to be lower in individuals with eczema, supplementation helps ease flare-ups and strengthens the skin barrier.

QSHIELD® (Quadruple Coating Technology): Consists of a water-soluble polymer, hyaluronic acid, porous particle, and soy-free protein to protect probiotics from heat, stomach acid, and bile, ensuring effective delivery to the gut.